ARPI MATOSSIAN ROGERS has a total of 12 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United Kingdom, New Zealand and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MATOSSIAN-ROGERS ARPI, SOPHERION THERAPEUTICS INC and KANSAI BUNRI SOGO GAKUEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 4 | |
#2 | New Zealand | 3 | |
#3 | Brazil | 2 | |
#4 | Israel | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Matossian-Rogers Arpi | 5 |
#2 | Matossian Rogers Arpi | 1 |
Publication | Filing date | Title |
---|---|---|
NZ595386A | Peptides for treatment and diagnosis of autoimmune disease | |
GB0609921D0 | Peptides | |
GB0516527D0 | Peptides | |
GB0423128D0 | Peptides | |
GB0326303D0 | Peptides |